InvestorsHub Logo
Followers 20
Posts 2113
Boards Moderated 0
Alias Born 05/10/2018

Re: None

Thursday, 04/30/2020 3:56:13 PM

Thursday, April 30, 2020 3:56:13 PM

Post# of 15175
The nano-particle versions were developed based on the Company's pending patents filed late last year. The Company utilized both botanically derived and pharmaceutical-grade synthetic tetrahydrocannabinol to develop these infusion technologies. $MCTC